...
首页> 外文期刊>Evidence-based cardiovascular medicine >Trial finds administering pravastatin early after symptom onset does not improve outcomes in people with acute coronary syndromes
【24h】

Trial finds administering pravastatin early after symptom onset does not improve outcomes in people with acute coronary syndromes

机译:试验发现症状发作后尽早使用普伐他汀不能改善急性冠脉综合征患者的预后

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In people with acute coronary events, the effect of administering statins early after symptom onset remains uncertain. The Pravastatin in Acute Coronary Treatment (PACT) study assessed the effects of administering pravastatin within 24 hours of symptom onset in people with unstable angina, non-ST-segment elevation myocardial infarction, or ST-segment elevation myocardial infarction. The primary endpoint was a composite of death, recurrence of myocardial infarction, or readmission to hospital for unstable angina within 30 days.
机译:在患有急性冠脉事件的人中,症状发作后早期服用他汀类药物的效果仍不确定。普伐他汀急性冠脉治疗(PACT)研究评估了不稳定型心绞痛,非ST段抬高型心肌梗塞或ST段抬高型心肌梗塞患者在症状发作后24小时内给予普伐他汀的效果。主要终点是死亡,心肌梗死复发或30天内因不稳定型心绞痛再次入院的复合结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号